Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vivo</i> BMAL1 occupancy mapping using MACS-Calling Cards reveals disease-associated retargeting in <i>Cln3</i> <sup><i>Δex7/8</i></sup> astrocytes.

bioRxiv : the preprint server for biology·2026
Same author

Antibiotic treatment reveals the contributions of the gut microbiome to CLN2 disease in the central and enteric nervous system.

Scientific reports·2026
Same author

Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease.

International journal of molecular sciences·2026
Same author

Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology.

Orphanet journal of rare diseases·2026
Same author

Limited therapeutic efficacy of N-acetyl-L-leucine in a mouse model of CLN1 disease.

Scientific reports·2025
Same author

Enteric nervous system degeneration in human and murine CLN3 disease, is ameliorated by gene therapy in mice.

Acta neuropathologica communications·2025
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Related Experiment Video

Updated: May 11, 2026

SorLA and CLC:CLF-1-dependent Downregulation of CNTFR&#945; as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

NCL disease mechanisms.

David N Palmer1, Lucy A Barry, Jaana Tyynelä

  • 1Department of Wine, Food and Molecular Biosciences, Faculty of Agricultural and Life Sciences, Lincoln University, PO Box 85084, Lincoln 7647, Christchurch, New Zealand.

Biochimica Et Biophysica Acta
|May 28, 2013
PubMed
Summary
This summary is machine-generated.

Neuronal ceroid lipofuscinoses (NCLs), or Batten disease, involve protein accumulation and neurodegeneration. This review explores current evidence on NCL disease mechanisms, including lysosomal dysfunction and neuroinflammation.

Keywords:
Biochemical abnormalitiesGlial activationPathogenesisSelective neuron lossStorage material accumulationSynaptic pathology

Related Experiment Videos

Last Updated: May 11, 2026

SorLA and CLC:CLF-1-dependent Downregulation of CNTFR&#945; as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Neuronal ceroid lipofuscinoses (NCLs), also known as Batten disease, are a group of rare genetic disorders.
  • NCLs are characterized by the accumulation of specific proteins in lysosome-derived organelles and progressive neurodegeneration.
  • Existing research points to impaired intracellular vesicle trafficking, lysosomal dysfunction, and neuroinflammation as key cellular events.

Purpose of the Study:

  • To review current evidence on the underlying disease mechanisms of NCLs.
  • To explore potential pathogenic pathways, including lysosomal dysfunction and neuroinflammation.
  • To discuss whether a unifying mechanism exists across different forms of NCLs.

Main Methods:

  • Literature review of biochemical, cell biology, and immunohistological studies.
  • Synthesis of evidence from various research approaches.
  • Analysis of proposed theories regarding NCL pathogenesis.

Main Results:

  • NCLs are defined by the accumulation of specific proteins (mitochondrial ATP synthase subunit c or SAPs A and D) and regional neurodegeneration.
  • Evidence suggests defects in lysosomal function and intracellular trafficking are common.
  • Neuroinflammation is strongly implicated, but its precise role and nature remain unclear.

Conclusions:

  • The precise molecular mechanisms driving NCL pathogenesis are still not fully understood.
  • Further research is needed to determine the central mechanisms and potential commonalities across NCL subtypes.
  • Understanding these mechanisms is crucial for developing effective treatments for these disabling neurological disorders.